patient
|
16 |
Age
|
44 |
Gender
|
male |
Origin
|
Germany |
Genotype
|
A |
PC_CP mutation
|
wt |
Weight(kg)
|
110 |
Duration of Pretreatment with Lamivudine (mo)
|
18 |
HBeAg Status at Baseline ADV
|
positive |
HBV DNA at Baseline ADV (log10 copies/mL)
|
4.78 |
Duration of ADV Therapy (mo)
|
28 |
HBV DNA at Baseline TDF (log10 copies/mL)
|
6.19 |